News

A clinical trial coordinated by IDIBELL validates a less aggressive surgery for lower rectal cancer

The study has been published by the JAMA Surgery journal, the most prestigious in the world in its field, and has been led by Dr Sebastiano Biondo, from IDIBELL and the Bellvitge University Hospital.

Leer más about A clinical trial coordinated by IDIBELL validates a less aggressive surgery for lower rectal cancer

The study of lysosomal function during cell division enables the identification of a new biomarker for chromosomal instability

By studying the role of lysosomes in mitosis, an IDIBELL and UB group discovers that alterations in the separation of chromosomes cause a detectable nucleus morphology once mitosis has finished. This morphology would be useful to identify cells that have chromosomal instability inherent in cancer cells.

Leer más about The study of lysosomal function during cell division enables the identification of a new biomarker for chromosomal instability

A study proposes a new approach for the identification of a syndrome of predisposition to childhood cancer

Patients with this syndrome have more mutations in the microsatellite regions of the genome. The detection of these mutations improves the diagnosis and therapeutic management of patients.

Leer más about A study proposes a new approach for the identification of a syndrome of predisposition to childhood cancer

The combination of four drugs at low doses is more effective and less toxic in the treatment of a lung cancer type

The study, published in the Nature Communications journal, and led by the Netherlands Cancer Institute (NKI), has had the collaboration of researchers from IDIBELL/ICO and HUB.
This study demonstrates the beneficial effect of treatment with a cocktail drug at low doses to block a single signaling pathway in a lung cancer type.

Leer más about The combination of four drugs at low doses is more effective and less toxic in the treatment of a lung cancer type

IDIBELL and Bellvitge Institute educational Tandem closes the course with a COVID-19 project

The educational Tandem, formed by the Bellvitge Institute and IDIBELL has closed the 2019-2020 academic year launching a challenge for 3rd ESO students: researching the new coronavirus. The emergence of COVID-19 and the situation of confinement motivated a project that aimed to promote knowledge and research on different aspects related to viruses, the human body […]

Leer más about IDIBELL and Bellvitge Institute educational Tandem closes the course with a COVID-19 project

Identified genes that predispose to cancer by impairing the protective function of the immune system

The study shows that the involvement of certain genes that predispose to cancer also affects the immune system, which could facilitate tumor growth.
In the specific case of breast cancer, the involvement of the SH2B3 gene, corresponding to a lymphocyte protein, increases the predisposition to develop cancer.

Leer más about Identified genes that predispose to cancer by impairing the protective function of the immune system

IDIBELL involves citizens with the survey «Health in times of confinement due to coronavirus»

The epidemic caused by the new coronavirus has negatively impacted millions of people around the world. Confinement has forced citizens to drastically change the way of relating, working and understanding everyday reality. To evaluate various parameters related to health and habits before and after confinement, the Psychiatry research group of the Bellvitge Biomedical Research Institute […]

Leer más about IDIBELL involves citizens with the survey «Health in times of confinement due to coronavirus»

Ribosome biogenesis senses nucleotide levels to preserve DNA integrity

When nucleotide levels drop, a common step during initiation of aggressive cancers, ribosomes biogenesis detects it and prevent DNA replication, as this could lead to genome damage.

Leer más about Ribosome biogenesis senses nucleotide levels to preserve DNA integrity
Scroll to Top